MyCap Mobile Application for Tracking Time Burden of Treatment for Patients With Pancreatic Cancer

Part of paid clinical trials in Columbus, Ohio.

Sponsor
Ohio State University Comprehensive Cancer Center
Study ID
NCT07619391
Status
Recruiting

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Electronic Health Record Review — OTHER
    Ancillary studies
  • Smartphone Application-based Intervention — BEHAVIORAL
    Receive access to MyCap application
  • Survey Administration — OTHER
    Ancillary studies

Study Details

This clinical trial tests the feasibility of using the MyCap mobile application (app) for tracking time burden from treatment for patients with pancreatic cancer. Pancreatic cancer is best treated with many care teams, such as medical oncology and surgery, requiring patients to dedicate significant time coordinating appointments among different doctors. This time commitment is referred to as time toxicity, defined as the time spent undergoing cancer-related medical care, such as emergency visits, ambulatory care, lab and infusion visits, hospitalizations, and the commuting and waiting times associated with each. At present, time toxicity is still understudied within the medical literature, with no gold standard established for the method of measurement. The MyCap mobile app may be a feasible way to track the time burden from treatment for patients with pancreatic cancer.

Key Dates

Start date
Mar 10, 2026
Status verified
May 2026
Primary completion
Dec 31, 2027
Completion
Dec 31, 2027

Study Design

Enrollment
30 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
HEALTH_SERVICES_RESEARCH

Arms

  • Experimental: Health Services Research (MyCap app)
    Patients download the MyCap app onto their phone and fill out a daily time log in the app for 8 weeks.

Primary Outcome Measure

Retention rate (feasibility) [ Time Frame: Up to 8 weeks ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Ohio State University Comprehensive Cancer CenterColumbusOhio43210
Pamela W. Lu, MD
614-293-7171
Pamela W. Lu, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Columbus, OH

By condition

Related Studies